MarketPulse

revenue manipulation

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

ADMA Biologics Faces Securities Fraud Investigation Amid Channel Stuffing Allegations

Pomerantz Law Firm investigates $ADMA for potential securities fraud after Culper Research alleges channel stuffing, with stock plunging 30% in two days.
ADMAsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Lowey Dannenberg, P.C.

ADMA Biologics Under SEC Investigation for Alleged Channel Stuffing Scheme

ADMA Biologics faces SEC investigation for allegedly inflating 2025 revenue growth from -3% actual to +20% reported through channel stuffing practices with distributors.
ADMAsecurities fraudinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Bleichmar Fonti & Auld Llp

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims

ADMA Biologics under fraud investigation after Culper Research alleged channel stuffing masked -3% actual revenue decline reported as +20% growth, causing 29% stock collapse.
ADMAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

ADMA Biologics Under Investigation for Alleged Channel Stuffing and Securities Violations

Law firm Kirby McInerney investigates $ADMA for potential securities violations. Culper Research alleges channel stuffing and undisclosed related-party distribution practices inflated 2025 growth.
ADMAsecurities fraudclass action investigation
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Allegations

ADMA Biologics faces securities fraud investigation for alleged channel stuffing, resulting in 29.1% stock decline to $9.63 per share.
ADMAsecurities fraudstock decline